DAVENPORT & Co LLC Has $3.92 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

DAVENPORT & Co LLC raised its stake in Colgate-Palmolive (NYSE:CLFree Report) by 0.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,136 shares of the company’s stock after acquiring an additional 361 shares during the period. DAVENPORT & Co LLC’s holdings in Colgate-Palmolive were worth $3,921,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth $32,000. Reston Wealth Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter worth $42,000. Synergy Asset Management LLC bought a new stake in Colgate-Palmolive during the 4th quarter worth $49,000. Capital Performance Advisors LLP bought a new stake in Colgate-Palmolive during the 3rd quarter worth $53,000. Finally, Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive during the 3rd quarter worth $64,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday. Raymond James restated an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday. UBS Group reduced their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday. Finally, Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and an average target price of $101.16.

Get Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Stock Up 0.4 %

CL stock opened at $87.05 on Tuesday. The stock’s 50 day simple moving average is $91.35 and its 200 day simple moving average is $97.15. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The company has a market cap of $71.12 billion, a P/E ratio of 24.73, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company posted $0.87 EPS. On average, research analysts expect that Colgate-Palmolive will post 3.74 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.